All premature infants < 1500 gm birth wt admitted within 8 hrs. of birth to one of the two study center NICU?s will be considered for possible inclusion in the study. Exclusion criteria include infants with known cerebral dysgenesis or in utero cerebral destructive events, or infants designated to receive limited life support interventions. After obtaining informed consent, cerebral oximetry optodes will be placed and NIRS data recorded continuously in time-locked manner with MAP via umbilical artery catheter. Daily 12-hr recordings for the first 5 days of life will be made. The NIRS-measured difference between oxyhemoglobin and deoxyhemoglobin, HbD, is assumed in this study to be an indicator of cerebral blood flow in these infants. The temporal and scalar relationship between the two signals (MAP and HbD) will be analyzed by means of coherence and transfer functions after visual screening by an investigator has eliminated artifact ridden segments. Results of this signal analysis will form the basis for categorizing each infant as either autoregulating or pressure-passive, and if the latter, will define degrees of severity of autoregulatory dysfunction. Extensive additional clinical data related to risk factors for PVL and hypoxia-ischemia will be recorded as obtained in the course of standard clinical care. These will include specific critical thresholds for hypercarbia, hypoxemia, and hypotensions; as well as serial measures of circulating cytokines. PVL will be detected by standard ultrasound imaging techniques, and by novel MRI and MR spectroscopic modalities. Scans will be obtained at the earliest feasible time and repeated at one year of age, at which time a standardized battery of neurologic and developmental examinations will be administered. With this design and methods, the investigators will test the following hypotheses: (1) concordant measures of cerebral and systemic hemodynamics using NIRS will distinguish autoregulating infants from pressure-passive infants; (2) critical abnormalities in MAP, PaO2 and PaCO2 will be associated with pressure-passive circulation; (3) higher circulating cytokine levels will be associated with pressure-passive circulation; (4) pressure-passive circulation is a precursor of PVL, and is associated with elevated lactate in cerebral white matter; (5) PVL visible in the neonatal period predicts abnormal myelin development, motor and cognitive handicap at one year of age.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS038475-03
Application #
6565273
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$196,099
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Jantzie, Lauren L; Talos, Delia M; Jackson, Michele C et al. (2015) Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex 25:482-95
Elitt, C M; Rosenberg, P A (2014) The challenge of understanding cerebral white matter injury in the premature infant. Neuroscience 276:216-38
Xu, Gang; Takahashi, Emi; Folkerth, Rebecca D et al. (2014) Radial coherence of diffusion tractography in the cerebral white matter of the human fetus: neuroanatomic insights. Cereb Cortex 24:579-92
Haynes, Robin L; van Leyen, Klaus (2013) 12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia. Dev Neurosci 35:140-54
Lippman-Bell, Jocelyn J; Rakhade, Sanjay N; Klein, Peter M et al. (2013) AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures. Epilepsia 54:1922-32
Haynes, Robin L; Sleeper, Lynn A; Volpe, Joseph J et al. (2013) Neuropathologic studies of the encephalopathy of prematurity in the late preterm infant. Clin Perinatol 40:707-22
Selip, D B; Jantzie, L L; Chang, M et al. (2012) Regional differences in susceptibility to hypoxic-ischemic injury in the preterm brain: exploring the spectrum from white matter loss to selective grey matter injury in a rat model. Neurol Res Int 2012:725184
Kinney, Hannah C; Haynes, Robin L; Xu, Gang et al. (2012) Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol 71:397-406
Manning, Simon M; Boll, Griffin; Fitzgerald, Erin et al. (2011) The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain. Int J Dev Neurosci 29:767-73
Volpe, Joseph J; Kinney, Hannah C; Jensen, Frances E et al. (2011) The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29:423-40

Showing the most recent 10 out of 102 publications